Finance

Beta
Lists
LXEO:NASDAQ
Lexeo Therapeutics Inc
$4.75
+1.06%
(+0.050) 1D
Jun 26, 9:35:35 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LXEO...
Open
$4.69
High
$4.92
Low
$4.67
Mkt. cap
375.33M
Avg. vol.
853.95K
Volume
1.31K
52-wk high
$10.99
52-wk low
$3.60
EPS
-$1.45
Shares outstanding
78.52M
No. of employees
59
Open
$4.69
High
$4.92
Low
$4.67
Mkt. cap
375.33M
Avg. vol.
853.95K
Volume
1.31K
52-wk high
$10.99
52-wk low
$3.60
EPS
-$1.45
Shares outstanding
78.52M
No. of employees
59
News stories
From sources across the web
About Lexeo Therapeutics Inc
CEO-
Employees59
Founded2017
Headquarters-
SectorBiotechnology
Websitelexeotx.com
Analyst ratings
Based on 6 analysts giving stock ratings to LXEO in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for LXEO in the last 3 months.
Highest
Current $4.75
$20.00 (+321.05%)
Average
$17.00 (+257.89%)
Lowest
$9.00 (+89.47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tessa Romero
J.P. Morgan
Buy
Maintained
$9.00
+89.5%
06/25/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$17.00
+257.9%
05/12/2026
Luca Issi
RBC Capital
Buy
Maintained
$20.00
+321.1%
05/11/2026
Unknown Analyst
Stifel Nicolaus
Buy
Maintained
$17.00
+257.9%
05/12/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$17.00
+257.9%
05/11/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$20.00
+321.1%
03/31/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$19.00
+300%
03/30/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
$10.00
+110.5%
01/13/2026
Christopher Raymond
Raymond James
Buy
Maintained
$25.00
+426.3%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
14.72M
15.70M
16.21M
15.70M
Cost of revenue
14.72M
15.70M
16.21M
15.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.97M
5.95M
6.91M
6.63M
Operating expense
15.97M
5.95M
6.91M
6.63M
Total operating expenses
30.69M
21.65M
23.12M
22.33M
Operating income
-30.69M
-21.65M
-23.12M
-22.33M
Other non operating income
-14.00K
-9.00K
9.00K
-1.00K
EBT including unusual items
-26.10M
-20.28M
-20.92M
-20.20M
EBT excluding unusual items
-29.46M
-20.22M
-20.91M
-20.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.10M
-20.28M
-20.92M
-20.20M
Net profit margin
-
-
-
-
Earnings per share
-0.68
-0.33
-0.27
-0.25
Interest and investment income
1.27M
1.46M
2.21M
2.11M
Interest expense
-25.00K
-22.00K
-20.00K
-17.00K
Net interest expenses
1.24M
1.43M
2.19M
2.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.55M
-21.50M
-22.96M
-22.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of LXEO
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer